# Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis

> **NCT04660747** · — · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 1300 (estimated)

## Conditions studied

- Cerebral Venous Thrombosis

## Interventions

- **DRUG:** Oral anticoagulant

## Key facts

- **NCT ID:** NCT04660747
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-27
- **Primary completion:** 2024-08
- **Final completion:** 2028-01
- **Target enrollment:** 1300 (ESTIMATED)
- **Last updated:** 2024-08-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04660747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04660747, "Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04660747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*